Document is current
Any future updates will be listed below
-
Authors
Bessen, Sarah Y.
Tackett, Sean
Jenks, Carolyn M.
Stewart, C. Matthew
Oliva-Hemker, Maria
Lee, Jennifer K.
-
Funding
Funding for this research was provided by:
National Institutes of Health (5T32DC000027-27)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 12 February 2025
First Online: 28 February 2025
Declarations
:
: This study was approved by the JH University Institutional Review Board (protocol IRB00365761) and adhered to the principles set forth in the Declaration of Helsinki. The JH University Institutional Review Board waived the requirement for informed consent. The JH University Institutional Review Board acknowledged all study procedures as exempt research and waived the requirement for consent (protocol IRB00365761).
: Not applicable.
: JKL consults for the United States Food and Drug Administration and Erickson Coaching International, and owns Asclepius Coaching and Consulting, LLC. MOH has funding from Takeda Pharmaceuticals and PredictImmune and consults for Takeda Pharmaceuticals and Janssen Research and Development.
